Helicobacter pylori y enfermedad por reflujo gastroesofágico

ANALES DEL SISTEMA SANITARIO DE NAVARRA

Suplemento 2

Helicobacter pylori y enfermedad por reflujo gastroesofágico
Helicobacter pylori and gastro-oesophageal reflux disease

E. Sanz de Villalobos, D. Boixeda de Miquel

BIBLIOGRAFÍA

1. McCallum RW, De Luca V, Marshall BJ, Prakash C. Prevalence of Campylobacter-like organisms in patients with gastroesophageal reflux disease vs normals. Gastroenterology 1984; 92: 1524.

2. Borkent MR, Beker A. Treatment of ulcerative reflux esophagitis with colloidal bismuth subcitrate in combination with cimetidine. Gut 1988; 29: 385-389.

3. Cheng EH, Bermanski P, Silversmith M, Valenstein P, Kawanishi H. Prevalence of Campylobacter pylori in esophagitis, gastritis and duodenal disease. Arch Intern Med 1989; 149: 1373-1375.

4. Francoual S, Lamy PH, Le Quintrec Y, Luboinski J, Petit JC. Helicobacter pylori: Has it part in the lesion of the gastroesophageal reflux. J Infect Dis 1990; 162: 1414-1415.

5. O'Connor HJ, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease. A prospective study. Ir J Med Sci 1994; 163: 369.

6. Wittmann T, Fehér A, Rosztóczy A, Jármay K, Lénart Zs. Does the Helicobacter pylori infection aggravate gastroesophageal reflux disease (abstract). Gut 1995, 37: A224.

7. Boixeda D, Gisbert JP, Cantón R, Álvarez Baleriola I, Gil Grande LA, Martín de Argila C. ¿Por Helicobacter pylori y la esofatitis péptica?. Med Clin (Barc) 1995; 105: 774-777.

8. Kuipers EJ, Lundell L, Klinkenberg-Konl EC, Havu N, Festen HP, Liedman B et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-1022.

9. Newton M, Bryan R, Burnham WR, Kamm MA. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrettís oesophagus. Gut 1997; 40: 9-13.

10. Csendes A, Smok G, Cerda G, Burdiles P, Mazza D, Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophaheal reflux, erosive esophagitis or Barrettís esophagus. Dis Esophagus 1997; 10: 3842.

11. Deltenre M, DeKoster E, Ferhat M, Deprez C. Helicobacter pylori, gastric histology and gastro-oesophageal reflux disease (abstract). Gastroenterology 1995; 108: A81.

12. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrettís esophagus. Gastroenterology 1988; 95: 216-218.

13. Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrettís esophagus. Am J Gastroenterol 1992; 87: 1598-1600.

14. Hazell SL, Carrick J, Lee A. Campylobacter pylori can infect the oesophagus when gastric tisue is present (abstract). Gastroenterology 1988; 94: A178.

15. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrettís esophagus. Mayo Clin Proc 1988; 63: 1176-1180.

16. Gruppo operativo per lo studio delle precancerosi esofagee (GOSPE). Helicobacter pylori in Barrettís esophagus. Histopathology 1991; 18: 568-570.

17. Ferreres JC, Fernández F, Rodríguez-Vives A, González Rodilla I, Ursua I, Ramos R et al. Helicobacter pylori in Barrettís esophagus. Histol Histopathol 1991; 6: 403-408.

18. Shallcross Tm, Wyatt JI, Rathbone BJ, Heatley LV. Non-steroidal anti-inflammatory drugs, hiatus hernia, and Helicobacter pylori, in patients with oesophageal ulceration. Br J Rheumatol 1990; 29: 288-290.

19. Walker SJ, Birch PJ, Stewart M, Stoddard CJ, Hart CA, Day DW. Patterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenum. Gut 1989; 30: 1334-1338.

20. Éles Zs, Winternitz T, Kupcsulik P, Forgács A. Helicobacter pylori contamination in gastroesophageal reflux disease (abstract). Gut 1995; 37: A222.

21. Labenz J, Tillenburg B, Peitz U, Bórsch G. Long-term consecuences of Helicobacter pylori eradicatin: clinical aspects. Scand J Gastroenterol 1996; 31 (Suppl 215): 111-115.

22. Vicari J, Falk GW, Richter JE. Helicobacter pylori and acid peptic disorders of the esophagus. Is it conceivable?. Am J Gastroenterol 1997; 92: 1097-1102.

23. El-Omar EM, Penman ID, Ardill JES, Chittajallu RS, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691.

24. Peterson WL, Barnett CC, Evans DJ, Feldman M, Carmody T, Richardson C et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 1993; 88: 2038-2043.

25. Zhu H, Pace F, Sangaletti O, Bianchi-Porro G. Gastric acid secretion and pattern of gastroesophageal reflux in patients with esophagitis anda concomitant duodenal ulcer. Scand J Gastroenterol 1993; 28: 387-392.

26. Mullholland MW, Reid BJ, Levine DS, Rubin CE. Elevated gastric acid secretion in patients with Barrettís metaplastic epitelium. Dig Dis Sci 1989; 34: 1329-1335.

27. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109: 601-610.

28. Dodds WJ, Dent J, Hogan WJ, Helm JF, Hauser R, Patel GK et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307: 1547-1552.

29. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-1205.

30. Wegener M, BÛrsch G, Schaffstein J, Schultz-Flake C, Mai U, Leverkus F. Are dyspeptic symptoms in patients with Campylobacter pylori-associated type B gastritis linked to delayed gastric emptying? Am J Gastoenterol 1988, 83: 737-740.

31. Barnett J, Behler EM, Appelman HD et al. Campylobacter pylori is not associated with gastroparesis. Dig Dis Sci 1989; 34: 1677-1680.

32. Pieramico O, Ditschuneit H, Malfertheiner P. Gastrointestinal motility in patients with non-ulcer dyspepsia: a role for Helicobacter pylori infection?. Am J Gastroenterol 1993; 88: 364-368.

33. Scott AM, Kellow JE, Shuter B, Cowan H, Cobertt AM, Riley JW et al. Intragastric distribution and gastric emptying of solids and liquids in funtional dyspepsia. Lack of influence of symptom subgroups and H pylori-associated gastritis. Dig Dis Sci 1993; 38: 2247-2254.

34. Minocha A, Mokshagundam S, Gallo SH, Rahal PS. Alterations in upper gastointestinal motility in Helicobacter pylori-positive nonulcer dyspepsia. Am J Gastroenterol 1994; 89: 1797-1800.

35. Kao CH, Wang SJ, Chen GH, Yeh SH. The relationship between Helicobacter pylori-associated gastritis or ulcer disease and gastric emptying. Eur J Nucl Med 1994; 21: 209-211.

36. Perri F, Ghoos Y, Maes B, Annese V, Geypens B, Hiele M, Rutgeers P. Gastric emptying in patients with duodenal ulcer (DU) and Helicobacter pylori (HP) infection (abstract). Gastroenterology 1994; 106: A159.

37. Labenz J, Tillenburg B, Peitz U, Idstróm JP, Verd. EF, Stolte M et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-732.

38. Katelaris PH, Seow F, Lin BPC, Napoli J, Ngumc MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34: 1032-1037.

39. Cayla R, Carles B, De Mascarel A, Zerbib F, Lamouliatte H. Long term follow-up of chronic gastritis after persistent Helicobacter pylori eradication in duodenal ulcer patients (abstract). Gastroenterology 1995; 108: A68.

40. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649-653.

41. Yasunaga Y, Shinimura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-1574.

42. Pfeiffer A, Kr^mer W, Friemann J, Ruge M, Herawi M, Sch⋅tzl M et al. Muscarinic receptors in gastric mucosa are increased in peptic ulcer disease. Gut 1995; 36: 813-818.

43. Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CHS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991; 36: 1089-1096.

44. Guttu K, Sorbye H, Gislason H, Svanes K, Gronbech JE. Role of bicarbonate in blood flow-mediated protection and repair of damaged gastric mucosa in the cat. Gastroenterology 1994; 107: 149-159.

45. Beil W, Birkholz C, Wagner S, Sewing KF. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H/K-ATPase. Gut 1994; 35: 1176-1180.

46. Cave DR, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187-189.

47. Kaneko H, Nakada K, Mitsuma T, Uchida K, Furusawa A, Maeda Y et al. Helicobacter pylori infection induces a decrease in immu noreactive-somatostatin concen trations of human stomach. Dig Dis Sci 1992; 37: 409-416.

48. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.